Brown Advisory Inc. Grows Stock Position in agilon health, inc. (NYSE:AGL)

Brown Advisory Inc. boosted its position in agilon health, inc. (NYSE:AGLGet Rating) by 3.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,500,028 shares of the company’s stock after buying an additional 107,072 shares during the quarter. Brown Advisory Inc. owned approximately 0.86% of agilon health worth $88,757,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of AGL. O Dell Group LLC purchased a new position in shares of agilon health in the fourth quarter valued at $27,000. CIBC Asset Management Inc grew its position in shares of agilon health by 6.8% in the fourth quarter. CIBC Asset Management Inc now owns 16,710 shares of the company’s stock valued at $451,000 after purchasing an additional 1,068 shares in the last quarter. Advisor Group Holdings Inc. grew its position in shares of agilon health by 899.4% in the fourth quarter. Advisor Group Holdings Inc. now owns 1,669 shares of the company’s stock valued at $47,000 after purchasing an additional 1,502 shares in the last quarter. Gleason Group Inc. purchased a new position in shares of agilon health in the first quarter valued at $55,000. Finally, Victory Capital Management Inc. grew its position in shares of agilon health by 17.2% in the fourth quarter. Victory Capital Management Inc. now owns 24,052 shares of the company’s stock valued at $649,000 after purchasing an additional 3,531 shares in the last quarter. 96.24% of the stock is owned by hedge funds and other institutional investors.

agilon health Trading Up 0.3 %

Shares of AGL stock opened at $25.59 on Friday. The company has a quick ratio of 2.67, a current ratio of 2.67 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average price of $22.87 and a two-hundred day moving average price of $21.17. agilon health, inc. has a 12-month low of $14.36 and a 12-month high of $38.47. The firm has a market cap of $10.41 billion, a P/E ratio of -91.39 and a beta of 1.76.

agilon health (NYSE:AGLGet Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). agilon health had a negative return on equity of 9.79% and a negative net margin of 4.99%. During the same period in the prior year, the business posted ($0.06) EPS. Equities analysts anticipate that agilon health, inc. will post -0.11 EPS for the current fiscal year.

Insider Transactions at agilon health

In other news, insider Benjamin Kornitzer sold 5,396 shares of agilon health stock in a transaction dated Tuesday, May 10th. The stock was sold at an average price of $16.47, for a total value of $88,872.12. Following the transaction, the insider now owns 10,853 shares in the company, valued at $178,748.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, insider Benjamin Kornitzer sold 5,396 shares of agilon health stock in a transaction dated Tuesday, May 10th. The stock was sold at an average price of $16.47, for a total value of $88,872.12. Following the transaction, the insider now owns 10,853 shares in the company, valued at $178,748.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Michael L. Smith sold 145,874 shares of the business’s stock in a transaction dated Wednesday, May 25th. The shares were sold at an average price of $19.53, for a total value of $2,848,919.22. Following the transaction, the director now owns 4,126 shares in the company, valued at approximately $80,580.78. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 711,053 shares of company stock worth $16,617,223. Company insiders own 3.30% of the company’s stock.

Analysts Set New Price Targets

AGL has been the subject of several research analyst reports. BTIG Research initiated coverage on agilon health in a research note on Friday, June 24th. They set a “neutral” rating for the company. TheStreet raised agilon health from a “d+” rating to a “c-” rating in a research note on Friday, July 15th. Truist Financial lifted their price objective on agilon health from $30.00 to $33.00 and gave the company a “buy” rating in a research note on Thursday, July 14th. Deutsche Bank Aktiengesellschaft dropped their price objective on agilon health from $30.00 to $26.00 in a research note on Tuesday, May 10th. Finally, Guggenheim dropped their price objective on agilon health from $32.00 to $30.00 in a research note on Tuesday, May 10th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, agilon health currently has an average rating of “Moderate Buy” and a consensus price target of $33.50.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Read More

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLGet Rating).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.